AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 182 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 6.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $220,000 | +101.8% | 23,400 | +63.6% | 0.00% | 0.0% |
| Q2 2020 | $109,000 | +43.4% | 14,300 | +16.0% | 0.00% | – |
| Q1 2020 | $76,000 | -57.8% | 12,327 | -31.5% | 0.00% | -100.0% |
| Q2 2019 | $180,000 | -13.5% | 18,000 | +31.4% | 0.00% | +100.0% |
| Q4 2018 | $208,000 | -64.9% | 13,700 | -53.7% | 0.00% | -66.7% |
| Q3 2018 | $592,000 | +11.1% | 29,600 | +2.4% | 0.00% | +50.0% |
| Q3 2017 | $533,000 | +136.9% | 28,919 | +139.0% | 0.00% | +100.0% |
| Q2 2017 | $225,000 | -42.3% | 12,100 | +8.0% | 0.00% | -66.7% |
| Q4 2016 | $390,000 | +1158.1% | 11,200 | +775.0% | 0.00% | – |
| Q3 2016 | $31,000 | -29.5% | 1,280 | -32.6% | 0.00% | – |
| Q1 2016 | $44,000 | +528.6% | 1,900 | +1800.0% | 0.00% | – |
| Q2 2015 | $7,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,650,000 | $48,893,000 | 3.10% |
| Voce Capital Management LLC | 110,789 | $2,044,000 | 2.72% |
| Palo Alto Investors LP | 3,441,233 | $63,491,000 | 2.67% |
| FALCON POINT CAPITAL, LLC | 839,477 | $13,180,000 | 1.91% |
| EII CAPITAL MANAGEMENT, INC. | 119,690 | $2,208,000 | 0.83% |
| CLARK ESTATES INC/NY | 163,300 | $3,013,000 | 0.50% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 38,358 | $708,000 | 0.50% |
| Jabre Capital Partners S.A. | 120,000 | $2,214,000 | 0.43% |
| Credit Capital Investments LLC | 15,000 | $277,000 | 0.31% |
| Alambic Investment Management, L.P. | 151,442 | $2,794,000 | 0.30% |